Corona Remedies is set to make its stock market debut today, December 15, with shares to be listed on both the BSE and NSE. The IPO allotment was finalised last week, on December 11, following a highly encouraging response from investors across all categories.
The IPO witnessed remarkable demand, closing with an overall subscription of 137.04 times on the final day of bidding. Qualified Institutional Buyers (QIBs) were the most active participants, subscribing 278.52 times by the end of Day 3. They placed bids for over 35.89 crore shares, far exceeding the 12.88 lakh shares allocated to them.
Non-Institutional Investors (NIIs) also showed strong interest, subscribing 208.88 times, with bids for more than 20.18 crore shares against an allocation of 9.66 lakh shares. Retail investors contributed significantly as well, subscribing 28.73 times by bidding for 6.48 crore shares compared to the 22.55 lakh shares reserved for them.
The exceptional response across all segments highlights the strong market confidence in Corona Remedies ahead of its listing.
+ There are no comments
Add yours